Indivumed GmbHBooth 828Indivumed Therapeutics is a biotech company focused on precision oncology. We create screening-ready novel target packages and partner with the pharmaceutical industry to develop precision cancer therapeutics.
With our global network of selected partner clinics, we have created unique protocols and procedures to collect tissue of unmatched quality and variety. By systematically characterizing the tissue at a molecular level and linking it with longitudinal clinical data, we can unravel novel targets that would otherwise be undetectable.
Combining biomathematics, bioinformatics and cell biology, we identify targets and design proof-of-concept drug screening assays for successful development further down the pipeline.
We envision a world where precision therapy offers a cure for every cancer patient. To learn more about our mission, visit www.indivumed-therapeutics.com.
